254 related articles for article (PubMed ID: 9022747)
1. Novel DNA-directed alkylating agents consisting of naphthalimide, nitrogen mustard and lexitropsin moieties: synthesis, DNA sequence specificity and biological evaluation.
Gupta R; Liu J; Xie G; Lown JW
Anticancer Drug Des; 1996 Dec; 11(8):581-96. PubMed ID: 9022747
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, DNA sequence preferential alkylation and biological evaluation of N-mustard derivatives of distamycin and netropsin analogues.
Xie G; Gupta R; Lown JW
Anticancer Drug Des; 1995 Jul; 10(5):389-409. PubMed ID: 7639929
[TBL] [Abstract][Full Text] [Related]
3. DNA-Directed alkylating agents. 7. Synthesis, DNA interaction, and antitumor activity of bis(hydroxymethyl)- and bis(carbamate)-substituted pyrrolizines and imidazoles.
Atwell GJ; Fan JY; Tan K; Denny WA
J Med Chem; 1998 Nov; 41(24):4744-54. PubMed ID: 9822545
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological activity of alpha-bromoacryloyl lexitropsin conjugates.
Romagnoli R; Baraldi PG; Iaconinoto MA; Carrion MD; Tabrizi MA; Gambari R; Borgatti M; Heilmann J
Eur J Med Chem; 2005 Nov; 40(11):1123-8. PubMed ID: 16006014
[TBL] [Abstract][Full Text] [Related]
5. The role of base excision repair in the repair of DNA adducts formed by a series of nitrogen mustard-containing analogues of distamycin of increasing binding site size.
Brooks N; McHugh PJ; Lee M; Hartley JA
Anticancer Drug Des; 1999 Feb; 14(1):11-8. PubMed ID: 10363024
[TBL] [Abstract][Full Text] [Related]
6. DNA minor groove targeted alkylating agents based on bisbenzimidazole carriers: synthesis, cytotoxicity and sequence-specificity of DNA alkylation.
Smaill JB; Fan JY; Denny WA
Anticancer Drug Des; 1998 Dec; 13(8):857-80. PubMed ID: 10335264
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and biological evaluation of DNA sequence and minor groove selective alkylating agents.
Lee M; Rhodes AL; Wyatt MD; Forrow S; Hartley JA
Anticancer Drug Des; 1993 Jun; 8(3):173-92. PubMed ID: 8517912
[TBL] [Abstract][Full Text] [Related]
8. Sequence selectivity, cross-linking efficiency and cytotoxicity of DNA-targeted 4-anilinoquinoline aniline mustards.
McClean S; Costelloe C; Denny WA; Searcey M; Wakelin LP
Anticancer Drug Des; 1999 Jun; 14(3):187-204. PubMed ID: 10500495
[TBL] [Abstract][Full Text] [Related]
9. Adenine-containing DNA-DNA cross-links of antitumor nitrogen mustards.
Balcome S; Park S; Quirk Dorr DR; Hafner L; Phillips L; Tretyakova N
Chem Res Toxicol; 2004 Jul; 17(7):950-62. PubMed ID: 15257621
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, DNA sequence preferential alkylation and biological evaluation of N-mustard derivatives of Hoechst 33258 analogues.
Gupta R; Wang H; Huang L; Lown JW
Anticancer Drug Des; 1995 Jan; 10(1):25-41. PubMed ID: 7535056
[TBL] [Abstract][Full Text] [Related]
11. Sequence specificity of alkylation for a series of nitrogen mustard-containing analogues of distamycin of increasing binding site size: evidence for increased cytotoxicity with enhanced sequence specificity.
Wyatt MD; Lee M; Garbiras BJ; Souhami RL; Hartley JA
Biochemistry; 1995 Oct; 34(40):13034-41. PubMed ID: 7548062
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, DNA interactions and biological activity of DNA minor groove targeted polybenzamide-linked nitrogen mustards.
Atwell GJ; Yaghi BM; Turner PR; Boyd M; O'Connor CJ; Ferguson LR; Baguley BC; Denny WA
Bioorg Med Chem; 1995 Jun; 3(6):679-91. PubMed ID: 7582946
[TBL] [Abstract][Full Text] [Related]
13. N-(2-chloroethyl)-N-nitrosourea tethered to lexitropsin induces minor groove lesions at the p53 cDNA that are more cytotoxic than mutagenic.
Inga A; Chen FX; Monti P; Aprile A; Campomenosi P; Menichini P; Ottaggio L; Viaggi S; Abbondandolo A; Gold B; Fronza G
Cancer Res; 1999 Feb; 59(3):689-95. PubMed ID: 9973219
[TBL] [Abstract][Full Text] [Related]
14. DNA sequence-selective binding of head-to-tail linked bis-lexitropsins: relation of phasing to cytotoxic potency.
Guo D; Gupta R; Lown JW
Anticancer Drug Des; 1993 Oct; 8(5):369-97. PubMed ID: 8251044
[TBL] [Abstract][Full Text] [Related]
15. Mono- and dysfunctional nitrogen mustard analogues of the DNA minor groove binder pibenzimol. Synthesis, cytotoxicity and interaction with DNA.
Smaill JB; Fan JY; Papa PV; O'Connor CJ; Denny WA
Anticancer Drug Des; 1998 Apr; 13(3):221-42. PubMed ID: 9595035
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and evaluation of psorospermin/quinobenzoxazine hybrids as structurally novel antitumor agents.
Kim MY; Na Y; Vankayalapati H; Gleason-Guzman M; Hurley LH
J Med Chem; 2003 Jul; 46(14):2958-72. PubMed ID: 12825936
[TBL] [Abstract][Full Text] [Related]
17. Recent developments in sequence selective minor groove DNA effectors.
Reddy BS; Sharma SK; Lown JW
Curr Med Chem; 2001 Apr; 8(5):475-508. PubMed ID: 11281837
[TBL] [Abstract][Full Text] [Related]
18. Sequence-specific DNA alkylation of novel tallimustine derivatives.
Marchini S; Cozzi P; Beria I; Geroni C; Capolongo L; D'Incalci M; Broggini M
Anticancer Drug Des; 1998 Apr; 13(3):193-205. PubMed ID: 9595033
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and topoisomerase II inhibition activity of 4'-demethylepipodophyllotoxin-lexitropsin conjugates.
Gupta R; al-Said NH; Oreski B; Lown JW
Anticancer Drug Des; 1996 Jun; 11(4):325-38. PubMed ID: 8679055
[TBL] [Abstract][Full Text] [Related]
20. Efficient guanine alkylation through cooperative heterodimeric formation of duocarmycin A and distamycin A.
Isomura M; Sugiyama H; Saito I
Nucleic Acids Symp Ser; 1995; (34):47-8. PubMed ID: 8841545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
